During the past decade, Central Georgia Gynecologic Oncology conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 21 clinical trials were completed, i.e. on average, 190.9% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 12 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Georgia Gynecologic Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 10 trials, followed by "Gynecologic Oncology Group" with 6 trials sponsored, "GOG Foundation" with 5 trials sponsored, "SWOG Cancer Research Network" with 4 trials sponsored and "Alliance for Clinical Trials in Oncology" with 4 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Georgia Gynecologic Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Central Georgia Gynecologic Oncology" are "Fallopian Tube Endometrioid Adenocarcinoma" (5 trials), "Fallopian Tube Mucinous Adenocarcinoma" (5 trials), "Fallopian Tube Transitional Cell Carcinoma" (5 trials), "Primary Peritoneal Serous Adenocarcinoma" (5 trials) and "Endometrial Clear Cell Adenocarcinoma" (4 trials). Many other conditions were trialed in "Central Georgia Gynecologic Oncology" in a lesser frequency.

Most popular intervention types in "Central Georgia Gynecologic Oncology" are "Drug" (25 trials), "Other" (25 trials), "Biological" (12 trials), "Procedure" (5 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Paclitaxel" (13 trials), "Carboplatin" (11 trials), "Quality-of-Life Assessment" (11 trials) and "Cisplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Central Georgia Gynecologic Oncology" are 20 trials for "Female" genders, 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Central Georgia Gynecologic Oncology". undefined are not yet recruiting, 2 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Central Georgia Gynecologic Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Central Georgia Gynecologic Oncology, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".